HealthMore in Health→
Early CAR-T Results Point to a New Path for Long-Term HIV Control
Key Takeaways
- Two trial participants maintained undetectable HIV without ongoing medication after a single CAR-T infusion.
- The study is early and small, focused on safety and feasibility rather than broad efficacy.
- If replicated, the approach could push HIV treatment toward longer-lasting immune control.
DE
DT Editorial Team··via wired.com
